Galmed Pharmaceuticals Commences Patient Screening for Aramchol Pharmacokinetic and Food Effect Studies

[PR Newswire] – TEL AVIV, Israel, April 28, 2014 /PRNewswire/ — Galmed Pharmaceuticals Ltd. (GLMD) (Galmed), a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of l more

View todays social media effects on GLMD

View the latest stocks trending across Twitter. Click to view dashboard

See who Galmed is hiring next, click here to view